Expression of integrin α5 β1 in adenocarcinoma of gallbladder and its clinical implication

王鲁,蔡端,许祖德,张秀荣,赵仲华

DOI: https://doi.org/10.3760/j.issn:1001-9030.2000.01.008

2000-01-01

Abstract:Objective To investigate the integrin α5 β1 expression in adenocarcinoma of gallbladder and its relation with tumor differentiation, invasion, metastasis and prognosis. Methods The integrin α5 β1 expression was detected in 57 cases of gallbladder adenocarcinoma by using immunohistochemistry technique (PAP method) and 37 cases of chronic cholecystitis. Results The expression of integrin α5 β1 in 71.9 % cases of gallbladder carcinoma and 13.5 % cases of chronic cholecystitis was weaker than in the surrounding normal cholecystic mocusa. The positive rate of integrin α5 β1 was lower in poorly differentiated carcinoma group than in well differentiated group ( P 0.05). The positive rate of integrin α5 β1 was lower in metastatic carcinoma group than in non metastatic group ( P 0.05). The two year survival rate was higher in integrin α5 β1 positive group (32.5 %) than in negative group (11.3 %, P 0.05). Conclusion The weak or loss expression of integrin α5 β1 was related with differentiation and metastasis of gallbladder carcinoma. The expression of integrin α5 β1 might have prognostic value.